7-cyclohexyl-6-(4-phenylmethoxyphenyl)-N-(2H-tetrazol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
C27H26N8O2 — CID 15958072
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-cyclohexyl-6-(4-phenylmethoxyphenyl)-N-(2H-tetrazol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
7-cyclohexyl-6-(4-phenylmethoxyphenyl)-N-(2H-tetrazol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 15958072) has the molecular formula C27H26N8O2 and a molecular weight of 494.56 g/mol. Its IUPAC name is 7-cyclohexyl-6-(4-phenylmethoxyphenyl)-N-(2H-tetrazol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide.
Molecular Properties
| Compound Name | 7-cyclohexyl-6-(4-phenylmethoxyphenyl)-N-(2H-tetrazol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide |
|---|---|
| PubChem CID | 15958072 |
| Molecular Formula | C27H26N8O2 |
| Molecular Weight | 494.56 g/mol |
| Exact Mass | 494.22 |
| IUPAC Name | 7-cyclohexyl-6-(4-phenylmethoxyphenyl)-N-(2H-tetrazol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide |
| SMILES | O=C(Nc1nn[nH]n1)c1cnn2c(C3CCCCC3)c(-c3ccc(OCc4ccccc4)cc3)cnc12 |
| InChI | InChI=1S/C27H26N8O2/c36-26(30-27-31-33-34-32-27)23-16-29-35-24(20-9-5-2-6-10-20)22(15-28-25(23)35)19-11-13-21(14-12-19)37-17-18-7-3-1-4-8-18/h1,3-4,7-8,11-16,20H,2,5-6,9-10,17H2,(H2,30,31,32,33,34,36) |
| InChIKey | DWYAPXKFZFRAPJ-UHFFFAOYSA-N |
| XLogP | 4.79 |
| TPSA | 122.98 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 494.56 |
| LogP ≤ 5 | 4.79 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 15958072 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.